SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Tandem Diabetes Care Is Maintained at Buy by Truist Securities

Ratings actions from Benzinga: GMT) Tandem Diabetes Care Price Target Cut to $28.00/Share From $31.00 by Truist SecuritiesRatings actions from Benzinga

TNDM

Related stories